Understanding how specific microRNAs control gene expression and muscle cell development
Unraveling the biological roles of specific miRNAs, from experimental target identification through functional characterization
This study is looking at how tiny molecules called microRNAs, especially miR-1 and miR-206, help control muscle cell growth and development, which could lead to better understanding and treatments for muscle-related conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-11006356 on NIH RePORTER |
What this research studies
This research investigates the role of specific microRNAs, particularly miR-1 and miR-206, in regulating gene expression and muscle cell differentiation. By using cultured mouse muscle cells and in vivo experiments, the researchers aim to identify the mRNA targets of these microRNAs and understand how they influence cellular processes. The study employs advanced techniques to unravel the complex interactions between microRNAs and their targets, which could provide insights into muscle development and related disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions affecting muscle development or function, such as muscular dystrophies.
Not a fit: Patients with non-muscle related conditions or those not affected by muscle differentiation issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for muscle-related diseases by enhancing our understanding of muscle cell differentiation.
How similar studies have performed: Previous research has shown success in understanding the roles of microRNAs in various biological processes, indicating that this approach has potential for meaningful discoveries.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Kugel, Jennifer F. — University of Colorado
- Study coordinator: Kugel, Jennifer F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.